Advancing immunosuppression in liver transplantation: the role of regulatory T cells in immune modulation and graft tolerance
Clinical Transplantation and Research · 31.12.2024 · 38 (4) · 257-272
DOI: 10.4285/ctr.24.0059 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Transplantation and Research, online erschienen am 19.12.2024. Verfasst von Ji Won Han und 1 weiteren Autor:innen. Beteiligte Einrichtung: The Catholic University Liver Research Center, College of Medicine, The Catholic University of Korea, Seoul, Korea. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, South Korea, Seoul St. Mary’s Hospital, The Catholic University of Korea.
Abstract (Originalsprache)
Prolonged immunosuppressive therapy in liver transplantation (LT) is associated with significant adverse effects, such as nephrotoxicity, metabolic complications, and heightened risk of infection or malignancy. Regulatory T cells (Tregs) represent a promising target for inducing immune tolerance in LT, with the potential to reduce or eliminate the need for life-long immunosuppression. This review summarizes current knowledge on the roles of Tregs in LT, highlighting their mechanisms and the impact of various immunosuppressive agents on Treg stability and function. The liver's distinct immunological microenvironment, characterized by tolerogenic antigen-presenting cells and high levels of interleukin (IL)-10 and transforming growth factor-β, positions this organ as an ideal setting for Treg-mediated tolerance. We discuss Treg dynamics in LT, their association with rejection risk, and their utility as biomarkers of transplant outcomes. Emerging strategies, including the use of low-dose calcineurin inhibitors with mammalian target of rapamycin inhibitors, adoptive Treg therapy, and low-dose IL-2, aim to enhance Treg function while providing sufficient immunosuppression. Thus, the future of LT involves precision medicine approaches that integrate Treg monitoring with tailored immunosuppressive protocols to optimize long-term outcomes for LT recipients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Catholic University Liver Research Center, College of Medicine, The Catholic University of Korea, Seoul, Korea.
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
- Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Korea.
ORCID-Profile: Ji Won Han, Su-Hyung Park
Förderung
- National Research Foundation of Korea
- Ministry of Science and ICT, South Korea
- Seoul St. Mary’s Hospital, The Catholic University of Korea
Zitieren
APA
Han, J. W., & Park, S. H. (2024). Advancing immunosuppression in liver transplantation: the role of regulatory T cells in immune modulation and graft tolerance. Clinical Transplantation and Research, 38(4), 257-272. https://doi.org/10.4285/ctr.24.0059
Vancouver
Han JW, Park SH. Advancing immunosuppression in liver transplantation: the role of regulatory T cells in immune modulation and graft tolerance. Clinical Transplantation and Research. 2024;38(4):257-272. doi:10.4285/ctr.24.0059
BibTeX
@article{Han2024,
author = {Han, Ji Won and Park, Su-Hyung},
title = {Advancing immunosuppression in liver transplantation: the role of regulatory T cells in immune modulation and graft tolerance},
journal = {Clinical Transplantation and Research},
year = {2024},
volume = {38},
number = {4},
pages = {257--272},
doi = {10.4285/ctr.24.0059}
}
EUVIMED